TW325997B - Pharmaceutical composition for preventing and treating retinal diseases - Google Patents

Pharmaceutical composition for preventing and treating retinal diseases

Info

Publication number
TW325997B
TW325997B TW083100676A TW83100676A TW325997B TW 325997 B TW325997 B TW 325997B TW 083100676 A TW083100676 A TW 083100676A TW 83100676 A TW83100676 A TW 83100676A TW 325997 B TW325997 B TW 325997B
Authority
TW
Taiwan
Prior art keywords
pharmaceutical composition
preventing
retinal diseases
treating retinal
treating
Prior art date
Application number
TW083100676A
Other languages
English (en)
Inventor
Kaneyoshi Kato
Hiroshi Kuriyama
Hirosuke Naka
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of TW325997B publication Critical patent/TW325997B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
TW083100676A 1993-02-02 1994-01-27 Pharmaceutical composition for preventing and treating retinal diseases TW325997B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1564593 1993-02-02

Publications (1)

Publication Number Publication Date
TW325997B true TW325997B (en) 1998-02-01

Family

ID=11894457

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083100676A TW325997B (en) 1993-02-02 1994-01-27 Pharmaceutical composition for preventing and treating retinal diseases

Country Status (7)

Country Link
US (1) US5665769A (zh)
EP (1) EP0609822A1 (zh)
KR (1) KR940019299A (zh)
CN (1) CN1099611A (zh)
CA (1) CA2114694A1 (zh)
HU (1) HU214719B (zh)
TW (1) TW325997B (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9403855D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
AU5317296A (en) * 1995-03-24 1996-10-16 Francis V. Defeudis Methods for treating conditions associated with excess nitri c oxide
AU2001267864A1 (en) * 2000-06-29 2002-01-08 Mitsubishi-Tokyo Pharmaceuticals, Inc. Remedial agent for optic nerve disease and the like
CA2443918C (en) * 2001-04-11 2012-06-05 Senju Pharmaceutical Co., Ltd. Visual function disorder improving agents containing rho kinase inhibitors
JP2006507368A (ja) * 2002-09-29 2006-03-02 サーモディックス，インコーポレイティド ステロイド含有治療剤の網膜下投与方法；脈絡膜及び網膜に薬力学作用を局在化するための方法；並びに網膜疾患の治療及び／又は予防のための関連する方法
BR0317026A (pt) * 2002-12-06 2005-10-25 Alcon Inc Mìmicos de superóxido dismutase para o tratamento de distúrbios e doenças oculares
WO2006014484A2 (en) 2004-07-02 2006-02-09 Surmodics, Inc. Methods and devices for the treatment of ocular conditions
CN101180086A (zh) * 2005-04-08 2008-05-14 苏尔莫迪克斯公司 用于经视网膜下递送的持续释放植入物
US20090099557A1 (en) * 2006-06-15 2009-04-16 Sedarevic Olivia N Methods and compositions for optimizing the outcomes of refractive laser surgery of the cornea
JP2008184387A (ja) * 2007-01-26 2008-08-14 Shiseido Co Ltd Ａｄａｍ阻害剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO86439B (ro) * 1982-01-15 1985-03-31 Eli Lilly And Company Procedeu pentru prepararea unor derivati de acid ascorbic
JPS60130582A (ja) * 1983-12-19 1985-07-12 Takeda Chem Ind Ltd 食品用酸化防止剤，アスコルビン酸誘導体およびその製造法
ZA852614B (en) * 1985-05-17 1986-10-09 Takeda Chemical Industries, Ltd. Ascorbic acid ethers and their production
US4826872A (en) * 1986-12-03 1989-05-02 Takeda Chemical Industries, Ltd. Pharmaceutical composition for treatment of cataract
JP2574052B2 (ja) * 1990-05-25 1997-01-22 明治製菓株式会社 アスコルビン酸誘導体、その製法およびその用途

Also Published As

Publication number Publication date
HU214719B (hu) 1998-05-28
CA2114694A1 (en) 1994-08-03
KR940019299A (ko) 1994-09-14
US5665769A (en) 1997-09-09
HU9400290D0 (en) 1994-05-30
EP0609822A1 (en) 1994-08-10
HUT68007A (en) 1995-05-29
CN1099611A (zh) 1995-03-08

Similar Documents

Publication Publication Date Title
CA2125888A1 (en) Pharmaceutically active antioxidant containing composition and the method of its use to prevent and treat restenosis following angioplasty
HUT72317A (en) Use of venflaxine or 3-aryloxi-propaneamine derivatives for preparing pharmaceutical compositions for treatment of incontinence
IL175398A0 (en) Steroidal compounds and pharmaceutical compositions containing them for treating oxidative stress and inflammation
AU3153097A (en) Pharmaceutical for treatment of neurological and neuropsychiatric disorders
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
MX9707192A (es) Compuestos triciclicos de carbamato, utiles para la inhibicion de la funcion de la proteina g y paratratamiento de enfermedades proliferativas.
AU7010694A (en) A surgical instrument, particularly for operative treatment of the prostate gland
CA2084775A1 (en) Method of treating human prostatic adenocarcinoma
TW360678B (en) Synergistic stabilizer mixture for polyolefins
CA2163361A1 (en) Therapeutic substituted guanidines
CA2199844A1 (en) Compositions for the treatment of skin disorders
GR3029491T3 (en) Use of leflunomid for the inhibition of interleukin 1 beta.
DE69631609D1 (en) Tricyclische erythromycinderivate
EP0773022A3 (de) Pharmazeutische Zubereitung zur Behandlung akuter Rhinitiden, enthaltend Sympthomimeticum und Pantothenol und/oder Pantothensäure
EP0646007A1 (en) NEW DELTA-17 AND DELTA-20 UNSATURATED AND SATURATED 17 - g (b) -SUBSTITUTED-4-AZA-5-g (a) -ANDROSTAN-3-ON COMPOUNDS AS INHIBITORS OF 5-ALPHA REDUCTASE.
CA2157142A1 (en) Treatment of diseases caused by sebaceous gland disorders
TW325997B (en) Pharmaceutical composition for preventing and treating retinal diseases
AU4705193A (en) Medicaments for the treatment or prevention of elevated intraocular pressure
UA42719C2 (uk) Сполуки, композиції та способи, які інгібують протеази, для лікування та профілактики імуномедіаторних запальних хвороб
ZA941464B (en) Use of pregnane derivative
AU4175893A (en) Treatment of inflammatory bowel disease
AU7675896A (en) Sulfur containing di-tert-butylphenol compounds useful as anti-inflammatory agents
AU2806692A (en) Medicament for the treatment of anxiety
IL105475A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS
AU1081695A (en) The use of an ester of inositoltrisphosphate for the preparing of medicaments